Ibrutinib combined with rituximab in treatment-naive patients with follicular lymphoma: Arm 1 + Arm 2 results from a multicenter, open-label phase 2 study Meeting Abstract


Authors: Fowler, N.; Nastoupil, L.; de Vos, S.; Knapp, M.; Flinn, I. W.; Chen, R. W.; Advani, R. H.; Bhatia, S.; Martin, P.; Mena, R.; Suzuki, S.; Beaupre, D. M.; Neuenburg, J. K.; Palomba, M. L.
Abstract Title: Ibrutinib combined with rituximab in treatment-naive patients with follicular lymphoma: Arm 1 + Arm 2 results from a multicenter, open-label phase 2 study
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452307142
PROVIDER: wos
DOI: 10.1182/blood.V128.22.1804.1804
Notes: Meeting Abstract: 1804 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba